Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: Clinical implications
Publication
, Other
Kwiatkowski, DJ; Harpole, DH; Godlewski, J; Herndon, JE; Shieh, DB; Richards, W; Blanco, R; Xu, HJ; Strauss, GM; Sugarbaker, DJ
Published in: Pneumologie
December 1, 1999
Duke Scholars
Published In
Pneumologie
ISSN
0934-8387
Publication Date
December 1, 1999
Volume
53
Issue
2
Start / End Page
105
Related Subject Headings
- Respiratory System
Citation
APA
Chicago
ICMJE
MLA
NLM
Kwiatkowski, D. J., Harpole, D. H., Godlewski, J., Herndon, J. E., Shieh, D. B., Richards, W., … Sugarbaker, D. J. (1999). Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: Clinical implications. Pneumologie.
Kwiatkowski, D. J., D. H. Harpole, J. Godlewski, J. E. Herndon, D. B. Shieh, W. Richards, R. Blanco, H. J. Xu, G. M. Strauss, and D. J. Sugarbaker. “Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: Clinical implications.” Pneumologie, December 1, 1999.
Kwiatkowski DJ, Harpole DH, Godlewski J, Herndon JE, Shieh DB, Richards W, et al. Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: Clinical implications. Vol. 53, Pneumologie. 1999. p. 105.
Kwiatkowski, D. J., et al. “Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: Clinical implications.” Pneumologie, vol. 53, no. 2, 1 Dec. 1999, p. 105.
Kwiatkowski DJ, Harpole DH, Godlewski J, Herndon JE, Shieh DB, Richards W, Blanco R, Xu HJ, Strauss GM, Sugarbaker DJ. Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: Clinical implications. Pneumologie. 1999. p. 105.
Published In
Pneumologie
ISSN
0934-8387
Publication Date
December 1, 1999
Volume
53
Issue
2
Start / End Page
105
Related Subject Headings
- Respiratory System